AGRX - Why Agile Therapeutics (AGRX) Stock Is Down 60% | Benzinga
Agile Therapeutics Inc (OTC:AGRX) shares are trading lower by 61% to $0.24 during Tuesday’s session after the company announced the suspension of its trading on the Nasdaq effective Tuesday. The company received a final delisting notice from Nasdaq due to its failure to meet the minimum stockholders’ ...
AGRX) Stock Is Down 60%>Full story available on Benzinga.com